These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 7880861)

  • 1. Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies.
    Maruyama K; Takizawa T; Yuda T; Kennel SJ; Huang L; Iwatsuru M
    Biochim Biophys Acta; 1995 Mar; 1234(1):74-80. PubMed ID: 7880861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEG-immunoliposome.
    Maruyama K
    Biosci Rep; 2002 Apr; 22(2):251-66. PubMed ID: 12428903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target.
    Klibanov AL; Maruyama K; Beckerleg AM; Torchilin VP; Huang L
    Biochim Biophys Acta; 1991 Feb; 1062(2):142-8. PubMed ID: 2004104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on preparation and biodistribution of PEG-immunoliposomes with active carboxylic terminals].
    Zhang YF; Xie SS; Hou XP; Gao X; Zhang S; Chen ZS
    Yao Xue Xue Bao; 2000 Nov; 35(11):854-9. PubMed ID: 11218866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid composition is important for highly efficient target binding and retention of immunoliposomes.
    Maruyama K; Kennel SJ; Huang L
    Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5744-8. PubMed ID: 2377612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo targeting by liposomes.
    Maruyama K
    Biol Pharm Bull; 2000 Jul; 23(7):791-9. PubMed ID: 10919354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes.
    Harding JA; Engbers CM; Newman MS; Goldstein NI; Zalipsky S
    Biochim Biophys Acta; 1997 Jul; 1327(2):181-92. PubMed ID: 9271260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of in vivo immunoliposome targeting to pulmonary endothelium.
    Maruyama K; Holmberg E; Kennel SJ; Klibanov A; Torchilin VP; Huang L
    J Pharm Sci; 1990 Nov; 79(11):978-84. PubMed ID: 2292774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possibility of active targeting to tumor tissues with liposomes.
    Maruyama K; Ishida O; Takizawa T; Moribe K
    Adv Drug Deliv Rev; 1999 Nov; 40(1-2):89-102. PubMed ID: 10837782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol).
    Maruyama K; Yuda T; Okamoto A; Kojima S; Suginaka A; Iwatsuru M
    Biochim Biophys Acta; 1992 Sep; 1128(1):44-9. PubMed ID: 1390877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.
    Kirpotin D; Park JW; Hong K; Zalipsky S; Li WL; Carter P; Benz CC; Papahadjopoulos D
    Biochemistry; 1997 Jan; 36(1):66-75. PubMed ID: 8993319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of long-circulating immunoliposomes containing adriamycin by a novel method to coat immunoliposomes with poly(ethylene glycol).
    Suzuki S; Watanabe S; Masuko T; Hashimoto Y
    Biochim Biophys Acta; 1995 Aug; 1245(1):9-16. PubMed ID: 7654771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodistribution and immunotargetability of ganglioside-stabilized dioleoylphosphatidylethanolamine liposomes.
    Litzinger DC; Huang L
    Biochim Biophys Acta; 1992 Feb; 1104(1):179-87. PubMed ID: 1550846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotargeting of liposomes containing lipophilic antitumor prodrugs.
    Mori A; Kennel SJ; Huang L
    Pharm Res; 1993 Apr; 10(4):507-14. PubMed ID: 8483832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly efficient immunoliposomes prepared with a method which is compatible with various lipid compositions.
    Holmberg E; Maruyama K; Litzinger DC; Wright S; Davis M; Kabalka GW; Kennel SJ; Huang L
    Biochem Biophys Res Commun; 1989 Dec; 165(3):1272-8. PubMed ID: 2610692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo.
    Mori A; Klibanov AL; Torchilin VP; Huang L
    FEBS Lett; 1991 Jun; 284(2):263-6. PubMed ID: 2060647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of organ-specific immunoliposomes for delivery of 3',5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine in a mouse lung-metastasis model.
    Mori A; Kennel SJ; van Borssum Waalkes M; Scherphof GL; Huang L
    Cancer Chemother Pharmacol; 1995; 35(6):447-56. PubMed ID: 7882453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of polyethyleneglycol (PEG)-derived lipid on the activity of target-sensitive immunoliposome.
    Ng K; Zhao L; Liu Y; Mahapatro M
    Int J Pharm; 2000 Jan; 193(2):157-66. PubMed ID: 10606778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targetability of novel immunoliposomes prepared by a new antibody conjugation technique.
    Bendas G; Krause A; Bakowsky U; Vogel J; Rothe U
    Int J Pharm; 1999 Apr; 181(1):79-93. PubMed ID: 10370205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of surface state of poly(ethylene glycol)-coated liposomes using an aqueous two-phase partitioning technique.
    Moribe K; Maruyama K; Iwatsuru M
    Chem Pharm Bull (Tokyo); 1997 Oct; 45(10):1683-7. PubMed ID: 9353897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.